Announcements Trials
Browse Landscape

Phase

Phase NA 33Phase 2 8Phase 3 4Phase 4 3Phase 1/2 3Phase 2/3 1Phase 1 1

Status

Unknown 2Recruiting 1

Sponsor Class

OTHER_GOV 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 104Carcinoma, Hepatocellular 103Stomach Neoplasms 62Pancreatic Neoplasms 46Liver Neoplasms 38Colonic Neoplasms 37Esophageal Neoplasms 28Rectal Neoplasms 22Neoplasms 13Neoplasm Metastasis 13Gastrointestinal Neoplasms 12Barrett Esophagus 11Recurrence 10Gastrointestinal Stromal Tumors 10Breast Neoplasms 10Bile Duct Neoplasms 10Pain, Postoperative 9Lung Neoplasms 8Cholangiocarcinoma 8Head and Neck Neoplasms 7Malnutrition 6Hepatitis B 6Carcinoma, Non-Small-Cell Lung 6Biliary Tract Neoplasms 6Agnosia 6Adenocarcinoma 6Prostatic Neoplasms 5Postoperative Complications 5Peptic Ulcer 5Pain 5

Interventions

Propranolol 1Nadolol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Liver Cirrhosis × Gastrointestinal × Clear all
NCT06084234 2025-11-26

TRACER

University of Texas Southwestern Medical Center

Phase 4 Recruiting
5,500 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

NCT01298284 2011-06-15

A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis

NCT00567216 2010-06-08

GVO-nadolol

Taipei Veterans General Hospital, Taiwan

Phase 4 Unknown
120 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡